EBQ talk:ProCESS Trial: Difference between revisions
No edit summary |
Ostermayer (talk | contribs) (→Protocol vs Non Protocol: new section) |
||
| Line 1: | Line 1: | ||
Hey, I haven't read the paper yet. When you say, "No significant 60 or 90 day mortality benefit was found to the '''protocol therapy'''," does "protocol therapy" refer to both the EGDT protocol group and the non-CVP, -inotrope, -transfusion protocol group or just the EGDT protocol group? -Ross | Hey, I haven't read the paper yet. When you say, "No significant 60 or 90 day mortality benefit was found to the '''protocol therapy'''," does "protocol therapy" refer to both the EGDT protocol group and the non-CVP, -inotrope, -transfusion protocol group or just the EGDT protocol group? -Ross | ||
== Protocol vs Non Protocol == | |||
Actually no statistical differences were found among any of the groups. Protocol, Protocol-EGDT, and "Usual Care". I think we will spell it out to make it more clear in the review | |||
Latest revision as of 20:12, 19 March 2014
Hey, I haven't read the paper yet. When you say, "No significant 60 or 90 day mortality benefit was found to the protocol therapy," does "protocol therapy" refer to both the EGDT protocol group and the non-CVP, -inotrope, -transfusion protocol group or just the EGDT protocol group? -Ross
Protocol vs Non Protocol
Actually no statistical differences were found among any of the groups. Protocol, Protocol-EGDT, and "Usual Care". I think we will spell it out to make it more clear in the review